Merging Microplates and Microarrays

Several companies offer arrays printed in microplate wells,1 but Tucson, Ariz.-based High Throughput Genomics Inc. (HTG) is the first to allow processing of small samples in the microplates prior to analysis. The result is "higher sensitivity and reproducibility," says HTG's CEO and president Bruce Seligmann, making the technology ideal for target gene validation or drug dose response profiling. Scientists can use HTG's Multiplexed Molecular Profiling (MMP) technology to assess protein functio

Laura Bonetta
Nov 25, 2001
Several companies offer arrays printed in microplate wells,1 but Tucson, Ariz.-based High Throughput Genomics Inc. (HTG) is the first to allow processing of small samples in the microplates prior to analysis. The result is "higher sensitivity and reproducibility," says HTG's CEO and president Bruce Seligmann, making the technology ideal for target gene validation or drug dose response profiling.

Scientists can use HTG's Multiplexed Molecular Profiling (MMP) technology to assess protein function and genetic polymorphisms, but the most popular application is measuring the RNA expression levels of a set of genes in multiple samples. Helen Brady, a scientist with San Diego-based Signal Pharmaceuticals, says her company has identified a number of interesting genes through array methods and is now using the HTG's ArrayPlate™ product "to look at the levels of a subset of genes under different conditions."

The technique works by adding linker oligonucleotides to a...

Interested in reading more?

The Scientist ARCHIVED CONTENT

ACCESS MORE THAN 30,000 ARTICLES ACROSS MANY TOPICS AND DISCIPLINES

Become a Member of

Receive full access to more than 35 years of archived stories, digital editions of The Scientist Magazine, and much more!
Already a member?